Harpagophytum procumbens in musculoskeletal disorders: current evidence and comparison with NSAIDs
Jin Young Hong, Junseon Lee, Hyunseong Kim, Hyun Kim, Wan-Jin Jeon, Changhwan Yeo, Yoon Jae Lee, Ho-Yeon Go, In-Hyuk Ha · 2026
Read Harpagophytum procumbens in musculoskeletal disorders: current evidence and comparison with NSAIDs by Jin Young Hong, Junseon Lee, Hyunseong Kim, Hyun Kim, Wan-Jin Jeon, Changhwan Yeo, Yoon Jae Lee, Ho-Yeon Go, In-Hyuk Ha (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13323821.txt.
Description
Jin Young Hong and co-authors review devil's claw for musculoskeletal pain against standard anti-inflammatory drugs, in a 2026 structured narrative review. The plant Harpagophytum procumbens is a traditional remedy whose use grows as long-term NSAID harms to gut, heart and kidneys limit care.
Lab work suggests its key compound harpagoside can damp inflammatory paths such as COX-2, NF-kB, cytokines and oxidative signals, though that proof is indirect. Clinical studies, mostly in osteoarthritis and low back pain, hint at symptom relief for some patients, yet trials are small, formulas and doses vary and follow-up is short. The authors judge NSAIDs still far better proven, with devil's claw generally well tolerated.
Catalog record
| CREATOR | Jin Young Hong, Junseon Lee, Hyunseong Kim, Hyun Kim, Wan-Jin Jeon, Changhwan Yeo, Yoon Jae Lee, Ho-Yeon Go, In-Hyuk Ha |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65125 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |